Virus expression and immunoprophylaxis of a murine lymphoma.
CBA mice tested with a rapidly lethal transplanted lymphoma could survive challenge when pretreated with allogeneic lymphoma cells or other material expressing murine leukemia virus (MuLV). Protection resulted when recipients were given injections of AKR and C3H transplanted lymphomas or selected normal AKR and SJL tissues, filtrates of which give positive assays for MuLV by in vitro and/or in vivo tests. There was no protection when recipients were given injections of C3H lymphomas or C3H normal tissues that failed to have positive assays for virus.
D000818:Animals; D002464:Cell Migration Inhibition; D002474:Cell-Free System; D006084:Graft Rejection; D007114:Immunization; D009052:Leukemia Virus, Murine / Q000276:immunology*; D008223:Lymphoma / Q000517:prevention & control*; D051379:Mice; D008806:Mice, Inbred AKR / Q000276:immunology; D008809:Mice, Inbred C3H / Q000276:immunology; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000517:prevention & control; D014184:Transplantation, Homologous; D010948:Viral Plaque Assay